EMA’s human medicines committee (CHMP) has adopted a positive scientific opinion for Acoziborole Winthrop for the treatment of human African trypanosomiasis (HAT; sleeping sickness) caused by Trypanosoma brucei gambiense (g-HAT).
EMA’s human medicines committee (CHMP) has adopted a positive scientific opinion for Acoziborole Winthrop for the treatment of human African trypanosomiasis (HAT; sleeping sickness) caused by Trypanosoma brucei gambiense (g-HAT).